reviewed and reviewedBy in
/js/regulatory.js. This banner disappears once you do.
The panel voted. Almost nothing changed.
What the July 2026 Pharmacy Compounding Advisory Committee actually decided, what it does not permit, and what to say when a clinic asks you about it.
If you read one thing
Six of seven peptides were recommended for the 503A bulks list on narrow margins. The committee is advisory and its votes are non-binding. Nothing has been added to the list, no rule has been proposed, and no compounding has been authorized. Anyone telling a clinic that BPC-157 is now FDA-cleared is wrong, and saying it yourself is the mistake most likely to cost you.
What the committee voted
| Substance | Indication considered | Outcome | Margin |
|---|
What this does and does not mean
Two separate things happened this year and they are easy to conflate. In April, seven peptides came off Category 2, which lifted an explicit do-not-compound posture. That is not the same as permission. In July, an advisory committee recommended six of them for the 503A bulks list. That is a recommendation, not a rule.
Between those two events sits a gray zone: no longer forbidden by name, not yet affirmatively allowed. Some pharmacies are compounding in that gap. That is a decision each pharmacy makes with its own counsel, and it is not a decision you should be characterising on their behalf.
How to answer when you are asked
- "An FDA advisory committee recommended six peptides for the 503A bulks list in July. The recommendation is non-binding."
- "Nothing has been added to the list yet. That takes a proposed rule, a comment period and a final rule."
- "Here is the published literature on that compound. I can send you the references."
- "Whether your pharmacy compounds it during the interim period is a question for your own counsel."
- "It's FDA approved now." It is not approved, and approval is a different thing entirely from the bulks list.
- "It's been cleared" or "it's legal now." Neither has happened.
- Any claim that a substance treats, prevents or cures a condition.
- "The FDA said it's safe." The committee split narrowly, and agency scientists opposed.
What happens next, and when
No deadline binds the agency. The honest answer to "when will this be settled" is that nobody knows, and the historical record suggests slowly.